Download PDF
Share this article
Research Article | Volume 29 Issue:1 (Jan-March, 2024) | Pages 24 - 29
Multiple sclerosis patients CCL5 levels
College of science, Kufa University, Iraq
Under a Creative Commons license
Open Access
Dec. 14, 2023
Jan. 1, 2024
Feb. 16, 2024
March 30, 2024

Aim of study multiple sclerosis (MS) is an autoimmune disorder affecting the central nervous system (CNS). This study aims to examine the CCL5 values in patients with Multiple Sclerosis. Patients and methodsA retrospective study was undertaken on 70 individuals diagnosed with multiple sclerosis utilising archived material. The RNA sequence of CCL5 was analysed using the real-time polymerase chain reaction (qPCR) technique. The CCL5 level was determined using quantitative polymerase chain reaction (RT-PCR) methodology. Results in total, a collection of 70 samples was obtained. The concentration of CCL5 was identified in all seventy patients and subsequently compared with a set of 30 control samples. There is an observed increase in the levels of CCL5 in patients diagnosed with Multiple Sclerosis (M.S) compared to individuals in good condition. Conclusion these findings provide support for the elevated levels of CCL5 observed in patients with Multiple Sclerosis. Moreover, compared to control cases, it appears that CCL5 correlates with a more unfavourable outcome in patients.

Recommended Articles
Short Commentary Article
Aortic valve implantation techniques--should they be any different for the pulmonary autograft and the aortic homograft?
Published: 21/09/2023
Download PDF
Case Report
Complejo Asistencial Universitario de León, León, Spain.
Download PDF
Research Article
The 'Pomeroy procedure': a new method to correct post-mitral valve repair systolic anterior motion
Published: 12/07/2001
Download PDF
Commentary Article
In response to: Bodnar E, Blackstone EH. Editorial: An 'actual' problem: another issue of apples and oranges. J Heart Valve Dis 2005; 14:706-708
Download PDF
Copyright © iARCON International LLP. All Rights Reserved.